Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast Accessibility StatementSkip NavigationSALT LAKE CITY, March 17, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its fourth quarter and full year 2025 financial results on Tuesday, March 31, 2026, after the market close. The Company wil ...